← All trends
World Wellness Guide
National Trend
Weight / metabolic

Obesity market: 5.8M searches a month

7.8M
searches/mo for the #1 result on "obesity demand-driver map"
1Mounjaro7.8M/mo7.8M2Glp 13.9M/mo, +10% 6mo3.9M3Tirzepatide3.2M/mo, +28% 6mo3.2M4Wegovy3M/mo, +9% 6mo3M5Semaglutide2.1M/mo2.1M6Zepbound1.1M/mo, +6% 6mo1.1M
Confidence: StrongAs of 2026-07-10

global · market pattern

Obesity market: 5.8M searches a month

About 5.8M people a month search Obesity across 30 tracked markets. The products this group turns to are led by Mounjaro, Glp 1, Tirzepatide.

What the Obesity economy actually looks like, sized by real search demand and the products people turn to.

What it isthe chronic metabolic condition of excess body fat

Working hypothesisAI-suggested

The obesity market is now GLP-1 first, Mounjaro and the tirzepatide family own most of the searchable demand.

The evidence

condition demand
5.8M searches a month for Obesity itself, summed across 30 tracked markets (2026-06) [MEASURED]
top linked demand
Mounjaro: 7.8M searches a month [MEASURED]
map
12 products mapped to Obesity in the demand-driver map [MEASURED edges, INFERRED that this population searches and buys them]
note
Headline is search demand for the condition term itself, a clean measured number. Linked products are ranked by their own global demand; they overlap across conditions (a GLP-1 search is not only a PCOS search), so they are shown as a leaderboard, not summed into a single market size. Money and sales are not measured.

The full ranking

6 tracked · obesity demand-driver map.

  1. 1Mounjaro7.8M/mo
  2. 2Glp 13.9M/mo, +10% 6mo
  3. 3Tirzepatide3.2M/mo, +28% 6mo
  4. 4Wegovy3M/mo, +9% 6mo
  5. 5Semaglutide2.1M/mo
  6. 6Zepbound1.1M/mo, +6% 6mo